TORALIZUMAB
UNII KX44A9HM0B

Substance Identification & Data

This profile provides standardized clinical and technical data for Toralizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KX44A9HM0B.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 252662-47-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

KX44A9HM0B

CAS Registry Number

252662-47-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TORALIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C152696

National Cancer Institute reference terminology for clinical and research data.

INN ID

8232

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MM-32

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Toralizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TORALIZUMAB

Common Names & Synonyms

ANTI-CD 154 HUMAN-MOUSE MONOCLONAL ANTIBODY

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD40 LIGAND) (HUMAN-MOUSE MONOCLONAL IDEC-131 .GAMMA.1 CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-131 .KAPPA.-CHAIN, DIMER

TORALIZUMAB [INN]

TORALIZUMAB [USAN]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD40 LIGAND) (HUMAN-MOUSE MONOCLONAL IDEC-131 .GAMMA.1 CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-131 .KAPPA.-CHAIN, DIMER

SYS